Search

Your search keyword '"Hartikainen, Jaana M."' showing total 483 results

Search Constraints

Start Over You searched for: Author "Hartikainen, Jaana M." Remove constraint Author: "Hartikainen, Jaana M."
483 results on '"Hartikainen, Jaana M."'

Search Results

3. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

4. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

5. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

6. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

7. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

8. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

9. Genome-wide association study of germline variants and breast cancer-specific mortality.

13. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

14. Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction

15. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

16. RAD51B in Familial Breast Cancer.

17. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

18. Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

19. Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1

20. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

22. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

23. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

24. Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions

25. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

26. Evidence of Gene�Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

27. 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

29. Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

30. Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

31. Data from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

32. Supplementary Table 3 from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

33. Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

34. Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

35. Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

36. Supplementary Table 1 from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

38. Supplementary Table 2 from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

39. Supplementary Table 4 from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

43. Data from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

50. Supplementary Tables 1-13 from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

Catalog

Books, media, physical & digital resources